1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow ANX005: new trials by email Literature Review of ANX005 trials Research Report on ANX005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) Tanruprubart - Guillain-Barre Syndrome | Phase 3 | Recruiting | Annexon, Inc. | 30 | 2025-09-12 | 2026-10-26 |
| Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome ANX005, Placebo - Guillain-Barre Syndrome | Phase 3 | Completed | Annexon, Inc. | 242 | 2020-12-17 | 2025-05-29 |
Annexon, Inc. (2)
Bangladesh (1) · Denmark (1) · France (1) · Philippines (1) · Spain (1) · United Kingdom (1) · United States (1)
2025 (1)